Detalhe da pesquisa
1.
Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian Registry.
Clin Infect Dis
; 72(11): e799-e805, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33677545
2.
Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3â¯cm in potentially transplantable patients.
J Hepatol
; 70(5): 866-873, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30615906
3.
Splenectomy as Flow Modulation Strategy and Risk Factors of De Novo Portal Vein Thrombosis in Adult-to-Adult Living Donor Liver Transplantation.
Liver Transpl
; 24(9): 1209-1220, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30146768
4.
Liver Transplantation is a Preferable Alternative to Palliative Therapy for Selected Patients with Advanced Hepatocellular Carcinoma.
Ann Surg Oncol
; 24(7): 1843-1851, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28160137
5.
Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control study.
Transpl Int
; 30(11): 1140-1149, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28686307
6.
Leflunomide for the treatment of trichodysplasia spinulosa in a liver transplant recipient.
Transpl Infect Dis
; 19(4)2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28326649
7.
Identifying candidates with favorable prognosis following liver transplantation for hepatocellular carcinoma: Data mining analysis.
J Surg Oncol
; 112(1): 72-9, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26032085
8.
Protease inhibitor-based triple therapy is highly effective for hepatitis C recurrence after liver transplant: a multicenter experience.
Ann Hepatol
; 13(5): 525-32, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25152985
9.
Virological response for recurrent hepatitis C improves long-term survival in liver transplant recipients.
Transpl Int
; 26(1): 42-9, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23137287
10.
Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection.
Ann Hepatol
; 12(2): 282-93, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23396740
11.
The long-term efficacy of nucleos(t)ide analog plus a year of low-dose HBIG to prevent HBV recurrence post-liver transplantation.
Clin Transplant
; 26(5): E561-9, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23061767
12.
Impact of Sofosbuvir-Based Regimens for the Treatment of Hepatitis C After Liver Transplant on Renal Function: Results of a Canadian National Retrospective Study.
Exp Clin Transplant
; 17(1): 59-63, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29619910
13.
The Impact of Preexisting and Post-transplant Diabetes Mellitus on Outcomes Following Liver Transplantation.
Transplantation
; 103(12): 2523-2530, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30985734
14.
Immune checkpoint inhibitor therapy in a liver transplant recipient with a rare subtype of melanoma: a case report and literature review.
Melanoma Res
; 28(1): 61-64, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29140833
15.
Early Intervention With Live Donor Liver Transplantation Reduces Resource Utilization in NASH: The Toronto Experience.
Transplant Direct
; 3(6): e158, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28620642
16.
Sofosbuvir-Based Antiviral Therapy Is Highly Effective In Recurrent Hepatitis C in Liver Transplant Recipients: Canadian Multicenter "Real-Life" Experience.
Transplantation
; 100(5): 1059-65, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26950722
17.
Post-transplant lymphoproliferative disorder in liver recipients: Characteristics, management, and outcome from a single-centre experience with >1000 liver transplantations.
Can J Gastroenterol Hepatol
; 29(8): 417-22, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26076399
18.
High sustained virological response to pegylated interferon and ribavirin for recurrent genotype 3 hepatitis C infection post-liver transplantation.
Hepatol Int
; 9(1): 76-83, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25788382
19.
One year of hepatitis B immunoglobulin plus tenofovir therapy is safe and effective in preventing recurrent hepatitis B post-liver transplantation.
Can J Gastroenterol Hepatol
; 28(1): 41-4, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24212911
20.
Serum aspartate aminotransferase levels and previous histopathological findings enable reduction of protocol liver biopsies after liver transplantation for hepatitis C.
Can J Gastroenterol
; 27(3): 131-6, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23516677